Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo
- 1 February 2004
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 31 (2), 257-267
- https://doi.org/10.1016/j.nucmedbio.2003.08.003
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agentsNuclear Medicine and Biology, 2002
- Synthesis of MMP inhibitor radiotracers [11C]methyl-CGS 27023A and its analogs, new potential PET breast cancer imaging agentsJournal of Labelled Compounds and Radiopharmaceuticals, 2002
- Matrix metalloproteinases: a tail of a frog that became a princeNature Reviews Molecular Cell Biology, 2002
- Matrix Metalloproteinases in Vascular Remodeling and AtherogenesisCirculation Research, 2002
- MMP Inhibitor radiotracer [11C]methyl‐CGS 27023A: A new pet breast cancer imaging agentJournal of Labelled Compounds and Radiopharmaceuticals, 2001
- Structural studies of matrix metalloproteinasesJournal of Molecular Medicine, 2000
- Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosisExpert Opinion on Investigational Drugs, 2000
- Marimastat (BB2516): Current status of developmentCancer Chemotherapy and Pharmacology, 1999
- Discovery of CGS 27023A, a Non-Peptidic, Potent, and Orally Active Stromelysin Inhibitor That Blocks Cartilage Degradation in RabbitsJournal of Medicinal Chemistry, 1997
- Matrix Metalloproteinase Inhibition as a Novel Anticancer Strategy: A Review with Special Focus on Batimastat and MarimastatPharmacology & Therapeutics, 1997